SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017)
SELLAS Life Sciences (SLS) reported Tax Rate of 0.85% for Q4 2017, up 39.73% on a QoQ basis from 1.41% in Q3 2017.
SELLAS Life Sciences (SLS) has 2 years of Tax Rate data on file, last reported at 0.85% in Q4 2017.
- Quarterly Tax Rate changed N/A year-over-year to 0.85% in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 1.1% (changed N/A YoY) and the FY2021 annual result came in at 1.13%, up 103.0% from the prior year.
- Tax Rate grew to 0.85% in Q4 2017 per SLS's latest filing, from 1.41% in the prior quarter.
- Across five years, Tax Rate topped out at 22.91% in Q1 2013 and bottomed at 19.13% in Q2 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7.07 |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -0.85 |
| Dec 31, 2017 | -0.85 |
| Sep 30, 2017 | -1.41 |
| Sep 30, 2017 | -1.41 |
| Jun 30, 2017 | -2.38 |
| Jun 30, 2017 | -2.38 |
| Dec 31, 2013 | -2.65 |
| Dec 31, 2013 | -2.65 |
| Sep 30, 2013 | -14.26 |
| Sep 30, 2013 | -14.26 |
| Jun 30, 2013 | -19.13 |
| Jun 30, 2013 | -19.13 |
| Mar 31, 2013 | 22.91 |
| Mar 31, 2013 | 22.91 |